What It Is
Ondansetron is the generic name for Zofran®. The orally disintegrating tablet (ODT) form melts on the tongue, no water needed. Useful when nausea is acute. Prescribed as an adjunct to GLP-1 therapy for patients who experience breakthrough nausea during dose titration.
How It Works
Ondansetron blocks serotonin (5-HT3) receptors in the gut and brain that trigger the nausea reflex. It does not treat nausea by sedating you. It interrupts the chemical signal directly.
Who It's For
Patients on semaglutide or tirzepatide who experience nausea during the first 4–8 weeks of titration, or whenever a dose increase brings it back. Use as needed, not on a schedule.
Who Should Avoid It
Avoid in patients with congenital long QT syndrome. Use caution with other QT-prolonging medications. Not for chronic daily use.
Protocol & Pricing
OBP Pharmacy Price
$37.50/30 tablets
You pay pharmacy price. No markup.
Starting Dose
1 tablet (4mg) every 8 hours as needed for nausea
Form
Orally disintegrating tablet (4mg × 30 tablets per pack)
Dosing Protocol
1 tablet (4mg) dissolved on the tongue every 8 hours as needed. Maximum 3 tablets per 24 hours. Take 30–60 minutes before a GLP-1 injection if nausea is anticipated. 30 tablets per fill, $37.50.
Beyond Use Date
N/A (manufactured drug, follow expiration on package)
Use within this window from the date your vial is compounded. BUD is set per USP <797> sterile compounding standards and printed on every label.
Stacking Guide
Stacks Well With
Related Peptides
Semaglutide/B12
The gold standard GLP-1 for weight management, paired with B12 for energy support.
From $25/1.2mgSemaglutide/B6 + Glycine
Glycine-buffered semaglutide for patients who don't tolerate the B12 cofactor.
From $175/10mgTirzepatide/B12
Dual GIP/GLP-1 receptor agonist for enhanced metabolic support with B12.
From $45/12mgCommon questions about Ondansetron 4mg ODT
- What is ondansetron and why is it prescribed alongside peptide protocols?
- Ondansetron is a 5-HT3 serotonin receptor antagonist FDA-approved as Zofran for chemotherapy-induced and post-operative nausea. RxPepsDirect providers prescribe it as a PRN anti-nausea adjunct for patients on GLP-1 protocols (compounded tirzepatide and semaglutide), where titration nausea is the most common reason patients struggle to maintain the protocol. The 4 mg orally disintegrating tablet (ODT) provides relief within 30 minutes without requiring a glass of water.
- Is ondansetron safe to take with GLP-1s like tirzepatide and semaglutide?
- Yes. Ondansetron has no clinically meaningful drug-drug interaction with tirzepatide or semaglutide. It is one of the most-studied anti-nausea drugs in modern medicine and has been used safely alongside GLP-1s in millions of patient-courses. The most common side effects are mild headache and constipation. Ondansetron can prolong the QT interval at high doses, so patients with known long-QT syndrome or on QT-prolonging medications should ask their provider.
- How do I take the 4 mg ODT for nausea?
- Place one 4 mg orally disintegrating tablet on the tongue and let it dissolve (no water needed). Take at the first sign of nausea, ideally before nausea becomes severe. Most patients feel relief within 30 minutes. Do not exceed 8 mg in any 8-hour window without provider review.
- How often can I take ondansetron during GLP-1 titration?
- Ondansetron is dosed PRN (as needed) during the first 4 to 8 weeks of GLP-1 titration. A common pattern is one 4 mg ODT in the morning of the GLP-1 dose day if nausea typically peaks then. Do not exceed 8 mg in 8 hours without provider review. If you need to dose ondansetron more than 3 days per week to function, message your provider; the GLP-1 dose may need to step back instead.
- Are there contraindications for ondansetron?
- Avoid ondansetron with apomorphine (severe hypotension risk). Patients with congenital long-QT syndrome should not use ondansetron. Patients on QT-prolonging medications (some antidepressants, antipsychotics, antimicrobials) should ask their provider before starting. Use during pregnancy is generally considered acceptable for severe nausea but warrants provider review.
